tiprankstipranks
Advertisement
Advertisement
Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)
PremiumThe FlyAutolus Therapeutics reports Q1 EPS (27c), consensus (26c)
2M ago
Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M
Premium
The Fly
Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M
2M ago
Autolus Therapeutics Reports Strong Q1 Growth and Outlook
Premium
Company Announcements
Autolus Therapeutics Reports Strong Q1 Growth and Outlook
2M ago
Autolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
PremiumRatingsAutolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy Rating
3M ago
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
Premium
The Fly
Autolus Therapeutics files to sell 54.58M American Depositary Shares for holders
3M ago
Autolus Therapeutics files $150M mixed securities shelf
Premium
The Fly
Autolus Therapeutics files $150M mixed securities shelf
3M ago
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
PremiumThe FlyMidday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
3M ago
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
Premium
Company Announcements
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
3M ago
Morning Movers: AstraZeneca jumps following tozorakimab trial results
Premium
The Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100